ClearPoint Neuro, Inc.
Company Stats
- Market Cap
- $372.5M
- as of Sep 30, 2026
- Enterprise Value
- $377.4M
- Shares Outstanding
- 30.5M
- Free Float
- 39.1%
Income Statement
- Revenue
- $37.0M
- Operating Income
- -$24.2M
- Net Income
- -$25.5M
- EBITDA
- -$23.4M
- Revenue Growth, 3Y
- 21.6%
- FCF Margin, 3Y Avg
- -51.9%
- FCF Margin, Worst Year
- -66.1%
Cash Flow
- Free Cash Flow
- -$24.4M
- FCF Yield
- -6.6%
- Owner FCF Yield
- -8.8%
Balance Sheet
- Cash & Equivalents
- $45.9M
- Total Debt
- $50.9M
- Net Debt
- $5.0M
Returns & Capital
- SBC, 3Y Avg
- $7.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $37.0M | -$24.4M | -66.1% |
| FY2024 | $31.4M | -$9.2M | -29.4% |
| FY2023 | $24.0M | -$14.4M | -60.3% |
| FY2022 | $20.6M | -$16.4M | -79.9% |
| FY2021 | $16.3M | -$12.9M | -78.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Micro-Cap Earnings Roundup for Week of Oct. 26, 2026
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back